Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …

A potential target of precision nutrition in cancer therapeutics is the micronutrient selenium
(Se). Se is metabolized and incorporated as the amino acid selenocysteine (Sec) into 25 …

Dyslipidemia has been linked to breast cancer incidence. The aim of the present meta-
analysis was to further investigate the relationship between the serum lipid profile and …

Background. The metabolic syndrome is a clustering of hyperglycemia/insulin resistance,
hypertension, dyslipidemia, and obesity which are risk factors for cardiovascular disease …

Background: Association between metabolic syndrome (MetS) and incidence of breast
cancer remains to be validated. Moreover, whether menopausal status of the women affects …

Introduction Allostatic load (AL), a composite index, has been used to capture variation in life-
course stresses. However, few studies have been carried out among breast cancer patients …

The incidence of metabolic syndrome (MetS), which causes heart disease and stroke, has
increased significantly worldwide. Although many studies have revealed the relationship …

ApoB-lipoproteins and their components modulate intracellular metabolism and have been
associated with the development of neoplastic phenomena, such as proliferation, anchorage …

In the past century the western world has found a way to combat most communicative
diseases; however, throughout that time the prevalence of obesity, hyperglycemia, and …

Emerging evidence suggests that normal weight postmenopausal women with a relative
excess of body fat are at increased breast cancer risk. However, little is known about the …